Suzhou Industrial Park

Home page > News


NUSRI research team receives registration certificate for PR vaccine


Date:   |   Source:       Font Size:    A   A   A

Prof. Yuan Yuren, director of Bioengineering and Biomedicine Center at SIP-based NUS (Suzhou) Research Institute (NUSRI), and his team recently received the registration certificate for HN1201-ΔgE Strains, a kind of new pseudorabies (PR) vaccine they discovered in collaboration with SA Biotech (Suzhou) Pte Ltd and Pulike Biological Engineering Inc. It is reportedly the third registration certificate that the three parties managed to obtain in recent years for drugs against porcine diseases.

The new vaccine can help effectively prevent and control PR which, also called Aujeszky's disease, is a fatal viral disease in swine with symptoms similar to those of rabies. Its effectiveness has been testified in a complete set of clinical tests.


February 1, 2019